跳至主要内容
临床试验/NCT07562945
NCT07562945
尚未招募
不适用

Comparison of Continuous Erector Spinae Plane Block With Ropivacaine Versus No Block on Postoperative Pain, NF-κB Levels, Opioid Consumption, and Quality of Recovery in Patients Undergoing Elective Mastectomy

Aldy Aldy1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年5月1日最近更新:

概览

阶段
不适用
状态
尚未招募
发起方
Aldy Aldy
入组人数
40
试验地点
1
主要终点
Postoperative Pain Intensity

概览

简要总结

This study aims to evaluate the effect of continuous erector spinae plane block (CESPB) using ropivacaine on postoperative pain in patients undergoing elective mastectomy. In addition to pain control, this study investigates the impact of CESPB on systemic inflammatory response as measured by nuclear factor kappa B (NF-κB) levels, opioid consumption, and quality of recovery. Patients will be randomly assigned to receive CESPB or standard analgesia without block. Outcomes will be assessed within the first 24 hours after surgery. The findings are expected to provide evidence on the clinical and biological benefits of CESPB as part of multimodal analgesia in breast surgery.

详细描述

Breast cancer is one of the most common malignancies worldwide and frequently requires surgical management in the form of mastectomy. Postoperative pain following mastectomy remains a significant clinical problem, with a substantial proportion of patients experiencing moderate to severe pain. Inadequate pain control is associated with increased opioid consumption, delayed recovery, and a higher risk of developing chronic pain.

The inflammatory response plays an important role in postoperative pain, particularly through the activation of nuclear factor kappa B (NF-κB), a key transcription factor that regulates pro-inflammatory mediators. Increased NF-κB activity has been associated with enhanced nociception and poorer recovery outcomes. Therefore, perioperative strategies that can reduce both pain and inflammatory response are of clinical importance.

Continuous erector spinae plane block (CESPB) is a regional anesthesia technique that provides multidermatomal analgesia by delivering local anesthetic into the fascial plane adjacent to the erector spinae muscle. Compared to single-shot techniques, CESPB using a catheter allows prolonged and stable analgesia. Ropivacaine is commonly used due to its favorable safety profile and potential anti-inflammatory effects.

This study is designed as a randomized controlled trial to compare CESPB using ropivacaine with standard analgesia without block in patients undergoing elective mastectomy. The primary outcome is postoperative pain intensity within 24 hours after surgery. Secondary outcomes include NF-κB levels, opioid consumption, incidence of postoperative nausea and vomiting, and quality of recovery measured using the QoR-15 questionnaire.

By integrating clinical and biomolecular outcomes, this study aims to provide comprehensive evidence regarding the effectiveness of CESPB not only in pain control but also in modulating the inflammatory response and improving postoperative recovery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Outcome assessors will be blinded to group allocation. Due to the nature of the intervention, participants and care providers will not be blinded.

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients aged 18 to 65 years
  • Diagnosed with breast cancer
  • Scheduled for elective mastectomy under general anesthesia
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Able to understand and provide written informed consent
  • Body mass index (BMI) 18-29 kg/m²

排除标准

  • Contraindications to regional anesthesia
  • Contraindications or allergy to ropivacaine or local anesthetics
  • Inability to use a visual analog scale (VAS) for pain assessment
  • Inability to understand or operate patient-controlled analgesia (PCA)
  • History of chronic pain or ongoing infection requiring treatment
  • History of chronic analgesic use
  • History of autoimmune disease
  • Uncontrolled systemic disease

研究组 & 干预措施

Continuous Erector Spinae Plane Block With Ropivacaine

Experimental

Participants will receive continuous erector spinae plane block using ropivacaine via catheter placement under ultrasound guidance, in addition to standard postoperative analgesia.

干预措施: Continuous Erector Spinae Plane Block (Procedure)

Continuous Erector Spinae Plane Block With Ropivacaine

Experimental

Participants will receive continuous erector spinae plane block using ropivacaine via catheter placement under ultrasound guidance, in addition to standard postoperative analgesia.

干预措施: Ropivacaine (Drug)

Standard Analgesia Without Block

No Intervention

Participants will receive standard postoperative analgesia according to institutional protocol, including oral paracetamol, intravenous ketorolac and opioid-based analgesia (patient-controlled analgesia with morphine), without erector spinae plane block.

结局指标

主要结局

Postoperative Pain Intensity

时间窗: 24 hours after surgery

Postoperative pain intensity measured using a Visual Analog Scale (VAS) ranging from 0 to 100 mm, where higher scores indicate greater pain.

次要结局

  • Change in Nuclear Factor Kappa B Levels From Baseline(Baseline and 24 hours after surgery)
  • Opioid Consumption(24 hours after surgery)
  • Quality of Recovery(24 hours after surgery)
  • Postoperative Nausea and Vomiting(24 hours after surgery)

研究者

发起方
Aldy Aldy
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Aldy Aldy

Principal Investigator

Udayana University

研究点 (1)

Loading locations...

相似试验